|
1
|
Yin QW, Sun XF, Yang GT, Li XB, Wu MS and
Zhao J: Increased expression of microRNA-150 is associated with
poor prognosis in non-small cell lung cancer. Int J Clin Exp
Pathol. 8:842–846. 2015.PubMed/NCBI
|
|
2
|
Wang Z, Fu J, Diao D and Dang C:
Pre-operative plasma D-dimer level may predict the poor prognosis
within one year after the surgery for non-small cell lung cancer.
Zhongguo Fei Ai Za Zhi. 14:534–537. 2011.(In Chinese). PubMed/NCBI
|
|
3
|
Cooper S and Spiro SG: Small cell lung
cancer: Treatment review. Respirology. 11:241–248. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arumuggam N, Bhowmick NA and Rupasinghe
HP: A review: phytochemicals targeting JAK/STAT signaling and IDO
expression in cancer. Phytother Res. 29:805–817. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He L, Bi JJ, Guo Q, Yu Y and Ye XF:
Effects of emodin extracted from Chinese herbs on proliferation of
non-small cell lung cancer and underlying mechanisms. Asian Pac J
Cancer Prev. 13:1505–1510. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu JQ, Bao W and Lei JC: Emodin regulates
apoptotic pathway in human liver cancer cells. Phytother Res.
27:251–257. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li XX, Dong Y, Wang W, Wang HL, Chen YY,
Shi GY, Yi J and Wang J: Emodin as an effective agent in targeting
cancer stem-like side population cells of gallbladder carcinoma.
Stem Cells Dev. 22:554–566. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yaoxian W, Hui Y, Yunyan Z, Yanqin L, Xin
G and Xiaoke W: Emodin induces apoptosis of human cervical cancer
hela cells via intrinsic mitochondrial and extrinsic death receptor
pathway. Cancer Cell Int. 13:712013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chun-Guang W, Jun-Qing Y, Bei-Zhong L,
Dan-Ting J, Chong W, Liang Z, Dan Z and Yan W: Anti-tumor activity
of emodin against human chronic myelocytic leukemia K562 cell lines
in vitro and in vivo. Eur J Pharmacol. 627:33–41. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ok S, Kim SM, Kim C, Nam D, Shim BS, Kim
SH and Ahn KS, Choi SH and Ahn KS: Emodin inhibits invasion and
migration of prostate and lung cancer cells by downregulating the
expression of chemokine receptor CXCR4. Immunopharmacol
Immunotoxicol. 34:768–778. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Prudente S, Sesti G, Pandolfi A, Andreozzi
F, Consoli A and Trischitta V: The mammalian tribbles homolog
TRIB3, glucose homeostasis, and cardiovascular diseases. Endocr
Rev. 33:526–546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fontanesi L, Colombo M, Scotti E,
Buttazzoni L, Bertolini F, Dall'Olio S, Davoli R and Russo V: The
porcine tribbles homolog 3 (TRIB3) gene: Identification of a
missense mutation and association analysis with meat quality and
production traits in Italian heavy pigs. Meat Sci. 86:808–813.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wennemers M, Bussink J, Grebenchtchikov N,
Sweep FC and Span PN: TRIB3 protein denotes a good prognosis in
breast cancer patients and is associated with hypoxia sensitivity.
Radiother Oncol. 101:198–202. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nicoletti-Carvalho JE, Nogueira TC, Gorjão
R, Bromati CR, Yamanaka TS, Boschero AC, Velloso LA, Curi R, Anhê
GF and Bordin S: UPR-mediated TRIB3 expression correlates with
reduced AKT phosphorylation and inability of interleukin 6 to
overcome palmitate-induced apoptosis in RINm5F cells. J Endocrinol.
206:183–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang N, Zhang W, Xu S, Lin H, Wang Z, Liu
H, Fang Q, Li C, Peng L and Lou J: TRIB3 alters endoplasmic
reticulum stress-induced β-cell apoptosis via the NF-κB pathway.
Metabolism. 63:822–830. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miyoshi N, Ishii H, Mimori K, Takatsuno Y,
Kim H, Hirose H, Sekimoto M, Doki Y and Mori M: Abnormal expression
of TRIB3 in colorectal cancer: A novel marker for prognosis. Br J
Cancer. 101:1664–1670. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang X, Taeb S, Jahangiri S, Emmenegger
U, Tran E, Bruce J, Mesci A, Korpela E, Vesprini D, Wong CS, et al:
miRNA-95 mediates radioresistance in tumors by targeting the
sphingolipid phosphatase SGPP1. Cancer Res. 73:6972–6986. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Z, Lv Y, Zhao N, Guan G and Wang J:
Protein kinase R-like ER kinase and its role in endoplasmic
reticulum stress-decided cell fate. Cell Death Dis. 6:e18222015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Leamy AK, Egnatchik RA, Shiota M, Ivanova
PT, Myers DS, Brown HA and Young JD: Enhanced synthesis of
saturated phospholipids is associated with ER stress and
lipotoxicity in palmitate treated hepatic cells. J Lipid Res.
55:1478–1488. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cho JA, Zhang X, Miller GM, Lencer WI and
Nery FC: 4-Phenylbutyrate attenuates the ER stress response and
cyclic AMP accumulation in DYT1 dystonia cell models. PLoS One One.
9:e1100862014. View Article : Google Scholar
|
|
21
|
Wei W-T, Lin S-Z, Liu D-L and Wang Z-H:
The distinct mechanisms of the antitumor activity of emodin in
different types of cancer (Review). Oncol Rep. 30:2555–2562.
2013.PubMed/NCBI
|
|
22
|
Pluquet O, Pourtier A and Abbadie C: The
unfolded protein response and cellular senescence. A review in the
theme: Cellular mechanisms of endoplasmic reticulum stress
signaling in health and disease. Am J Physiol Cell Physiol.
308:C415–C425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lakshmanan AP, Harima M, Suzuki K,
Soetikno V, Nagata M, Nakamura T, Takahashi T, Sone H, Kawachi H
and Watanabe K: The hyperglycemia stimulated myocardial endoplasmic
reticulum (ER) stress contributes to diabetic cardiomyopathy in the
transgenic non-obese type 2 diabetic rats: A differential role of
unfolded protein response (UPR) signaling proteins. Int J Biochem
Cell Biol. 45:438–447. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vidal RL, Figueroa A, Court FA, Thielen P,
Molina C, Wirth C, Caballero B, Kiffin R, Segura-Aguilar J, Cuervo
AM, et al: Targeting the UPR transcription factor XBP1 protects
against Huntington's disease through the regulation of FoxO1 and
autophagy. Hum Mol Genet. 21:2245–2262. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fribley AM, Miller JR, Reist TE, Callaghan
MU and Kaufman RJ: Large-scale analysis of UPR-mediated apoptosis
in human cells. Methods Enzymol. 491:57–71. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Guo Y, Tang J, Jiang J and Chen Z:
New insights into the roles of CHOP-induced apoptosis in ER stress.
Acta Biochim Biophys Sin (Shanghai). 47:146–147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bromati CR, Lellis-Santos C, Yamanaka TS,
Nogueira TC, Leonelli M, Caperuto LC, Gorjão R, Leite AR, Anhê GF
and Bordin S: UPR induces transient burst of apoptosis in islets of
early lactating rats through reduced AKT phosphorylation via
ATF4/CHOP stimulation of TRB3 expression. Am J Physiol Regul Integr
Comp Physiol. 300:R92–R100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang R, Cao X, Wang C, Hou L, Nie J, Zhou
M and Feng Y: An antitumor peptide from Musca domestica pupae
(MATP) induces apoptosis in HepG2 cells through a JNK-mediated and
Akt-mediated NF-κB pathway. Anticancer Drugs. 23:827–835. 2012.
View Article : Google Scholar : PubMed/NCBI
|
